|
|
||||||||
1 Cardiology Section, Department of Internal Medicine, National Taiwan University College of Medicine, National Taiwan University Hospital, 600 Taipei; 2 College of Medicine, National Cheng Kung University, Tainan; and 3 College of Public Health, National Taiwan University and 4 Department of Surgery, National Taiwan University Hospital, 600 Taipei, Taiwan
| |
ABSTRACT |
|---|
|
|
|---|
Distension of the
urinary bladder causes an increase in efferent sympathetic activity,
which can precipitate myocardial ischemia. Smoking has been shown to
modulate activities of afferent nerves from the distended urinary
bladder and to impair endothelial function in response to sympathetic
activation. To assess the effect of bladder distension on coronary
dynamics in smokers, we measured epicardial and microvascular responses
in 24 patients with early atherosclerosis (< 50% diameter stenosis).
Patients were classified into habitual smokers (group 1,
n = 14) and nonsmokers (group 2,
n = 10). Habitual smokers were randomized into two
subgroups on the basis of the use of doxazosin, as follows:
subgroup 1A (n = 7), without administration
of doxazosin before catheterization; subgroup 1B
(n = 7), with dosing doxazosin. In response to bladder distension (mean intravesical pressure 21.5 mmHg), bladder distension significantly decreased coronary diameter at the stenotic segments, coronary blood flow, and increased coronary resistance compared with
baseline values, in subgroup 1A patients. In subgroup
1B patients during bladder distension, coronary diameter, coronary blood flow, and coronary resistance did not show significant changes compared with baseline values. There were significant differences of
coronary diameter at the stenotic segments, coronary blood flow, and of
changes of coronary vascular resistance between subgroup 1A
and group 2 during bladder distension, despite similar
changes in rate-pressure product. The present study showed that urinary bladder distension caused an abnormal vasomotor response of epicardial vasoconstriction and a concomitant increased coronary resistance, which
leads to reduction in coronary blood flow in patients with early
atherosclerosis. Smoking may further impair the response, implying that
smoking has exaggerated response to sympathetic stimulation of conduit
and resistance vessels. The abnormal response was abolished by
pretreated administration of doxazosin, suggesting that the involved
mechanisms are related to
1-adrenoceptors.
intracoronary Doppler flow; urinary distension
| |
INTRODUCTION |
|---|
|
|
|---|
DISTENSION OF THE URINARY bladder has been shown to cause the reflex response of an increase in sympathetic activities (10, 34). The regulation of coronary blood flow by activated sympathetic nerves depends on status of coronary endothelial function (24). When the endothelium is impaired by atherosclerosis (12) or exhaustion of autoregulation (25), adrenergic-mediated vasoconstriction becomes unrestricted and sufficiently powerful to reduce coronary blood flow and initiate myocardial ischemia (23). Different maneuvers to elicit sympathetic activities, e.g., mental stress (48), handgrip (6), cold pressor test (1), and supine exercise (28), may differ in their recruitment of adrenergic-mediated coronary vasoconstriction. No studies have demonstrated the vasoconstriction reflex of the coronary arteries caused by the distension of the urinary bladder.
Smoking, a well-established risk factor for atherosclerosis (37), induces early impairment of endothelial function. Previous studies revealed the importance of endothelial function in both basal and stimulated control of vasomotor tone in large conduit and resistance vessels (27). Smoking has been shown to impair endothelial function in response to sympathetic activation in patients with coronary atherosclerosis (27). However, no previous data in smokers has been reported on the effect of urinary bladder distension on coronary circulation. In addition, when coronary flow was determined by the coronary sinus thermodilution method, the effects of interventions on regional myocardial flow cannot be assessed. To study the acute effects of urinary bladder distension on regional coronary circulation, we measured coronary blood flow by intracoronary Doppler flow-wire during such distension. The report describes clinical studies designed to test the hypothesis that there is an abnormal response of coronary conduit and resistance vessels during distension of the urinary bladder especially in smokers, by a combined intracoronary Doppler flow and quantitative coronary angiography.
| |
METHODS |
|---|
|
|
|---|
Patients
The study was conducted prospectively. Potential candidates were eligible for the present study if they had a single non-flow-limiting stenosis (<50% diameter stenosis) in the proximal or middle portion of one major coronary artery. Because severe atherosclerotic lesions of epicardial coronary artery may induce limited vasodilation and reflex vasoconstriction (6), only patients with mild stenosis were included. Exclusion criteria included prior myocardial infarction, unstable angina pectoris, uncontrolled hypertension, ejection fraction <55% by catheterization study, valvular heart disease, diabetes mellitus, and echocardiographic left ventricular mass index >117 g/m2 for men and 104 g/m2 for women (15). Because of influence of smoking on autonomic function (40), we excluded patients with autonomic dysfunction to make baseline autonomic system of our study subjects homogenous by autonomic reflex evaluation (44). A total of consecutive 24 patients were included. Patients were classified into habitual smokers (group 1, n = 14) and nonsmokers (group 2, n = 10, individuals who had never smoked). Habitual smokers were randomized into two subgroups on the basis of the use of doxazosin, as follows: subgroup 1A (n = 7), without administration of doxazosin before catheterization; subgroup 1B (n = 7), with dosing doxazosin. A habitual smoker was defined as someone who had regularly smoked each day for the previous 10 years regardless of the amount smoked. The clinical characteristics of patients were given in Table 1. The study was approved by the National Taiwan University Hospital Review Board, and all subjects provided informed written consent before participation. Medications, including calcium channel blockers and
-adrenergic blockers, and
caffeine-containing drinks were held for 48 h before the
procedure, except doxazosin for subgroup 1B
patients. Any patients who had taken nitroglycerin within
4 h of catheterization were excluded from this study. All subjects refrained from smoking for more than 12 h before the study.
|
Study Protocol
Catheterization procedures. Diagnostic left catheterization and angiography were performed from a femoral approach. After completion of the diagnostic catheterization, intravenous heparin was supplemented to maintain activated clotting time at 300 to 350 s, and a 7-French Judkins catheter was advanced to the ostium of the left or right coronary artery. A 0.014-in. Doppler wire (FloWire, Cardiometrics, Mountain View, CA) was first introduced through a standard angioplasty-type Y-connector attached to the angiographic catheter into the proximal coronary artery that had nonobstructive lesions (<50%). The wire tip was positioned such that a characteristic and stable flow velocity waveform was obtained. Three pairs of perpendicular views (90°) of the left and right coronary arteries were obtained. The precise angle, skew rotation, and table height of each projection were recorded so that the projection could be duplicated. Serial hand injections of contrast medium were performed at baseline and during urinary bladder distension. At each time interval, intracoronary Doppler flow was recorded, followed by coronary angiography.
Intervention procedures.
All study subjects underwent a post-voiding residual catheterization to
empty the bladder. An 8-French transurethral catheter was used to fill
the bladder with normal saline at room temperature and was then
attached to a water-filled line and pressure transducer, which was
zeroed to atmospheric pressure. This line measured intravesical pressure. Aortic blood pressure, heart rate, coronary angiograms, intravesical pressure, and intracoronary Doppler velocity were obtained
at baseline. Normal saline was then installed slowly from two 50-ml
syringes through the catheter while the intravesical pressure was
constantly monitored. If the intravesical pressure reached 20 mmHg or
increased such that there was a risk of leakage into the urethra, then
normal saline was withdrawn. The pressure level (20 mmHg) was chosen
because the intravesical pressures were at least 17 mmHg in subjects
with normal bladder function during micturition
(14). The technique allows distension of the bladder to be
maintained at a steady urinary bladder pressure in terms of maximal
variation in bladder pressure of less than 10%. Because rate of
filling influences the bladder's ability to accommodate an increasing
volume and test results (8), the filling rate was
controlled at 50-100 ml/min. The same measurements were obtained 5 min after the stable conditions of distension of the urinary bladder.
To examine the mechanism of the coronary flow response to distension of
the urinary bladder, the patients in subgroup 1B were
pretreated with the selective
1-blocker doxazosin (2 mg
po) 4 h before cardiac catheterization. The dose was selected because previous studies used the dose to obtain
-adrenergic block
(7).
Parameter Measurements
Angiography measurements. Digital coronary angiograms were recorded in three orthogonal projections before and after each procedure. For each lesion, the view showing the best demonstrated stenosis with minimal foreshortening was used for analysis. The minimal lumen diameter and proximal angiographically normal segment were measured. Quantitative measurements of coronary artery dimensions were made using a computer-based edge enhancement technique (DCI System; Philips, Best, The Netherlands), as previously described (32). The Doppler catheter was positioned ~5-10 mm proximal to the stenosis, far from any large branching vessel. To determine cross-sectional area of the artery, a 5-mm segment was measured immediately distal to the tip of the Doppler catheter. All injections and projections throughout a given study were performed by the same operator (T.-M. Lee) to minimize variability in angiographic technique. Three electrocardiographic leads were continuously recorded. These were selected to reflect leads showing electrocardiographic S-T segment changes during bladder distension. Ischemic electrocardiographic changes were defined as a horizontal or down-sloping S-T segment deviation of 0.1 mV or greater at 60 ms after the J point in any lead. Transient electrocardiogram (ECG) changes that were observed shortly after coronary arteriography were not taken to be a positive. During bladder distension, patients were asked to characterize the nature of chest pain and abdominal sensation. The degree of segmental vasoreactivity to bladder distention and nitroglycerin was expressed as the absolute vessel diameters and change percent. For angiographic normal reference vessel caliber in our laboratory, the intraobserver and interobserver differences for quantitative coronary angiography were 0.18 ± 0.15 mm (5.7 ± 6.2%) and 0.21 ± 0.23 mm (6.7 ± 6.8%), respectively.
Lactate measurements.
To confirm myocardial ischemia during urinary bladder distension,
selective catheterization of coronary sinus was successfully attempted
in the last 10 patients (3 in subgroup 1A, 3 in
subgroup 1B, and 4 in group 2). Simultaneous
samples of aortic root and coronary sinus at the same speed were
obtained for measurements of lactate contents. Myocardial lactate
extraction ratio (MLE, %) was calculated by the following formula:
MLE = [(LAo
LCS)/LAo] × 100, where LAO and
LCS represent plasma lactate concentrations in the aortic
root and in the coronary sinus, respectively.
Calculation of volumetric coronary blood flow and coronary resistance. The coronary flow velocity measurements were obtained with a Doppler ultrasound 0.014-in. guide wire. Digitized spectral peak velocity waveforms were averaged to compute the average peak velocity (APV). The monitor display was continuously recorded on Super VHS videotape for off-line analysis. Volumetric coronary blood flow (CBF, ml/min) was calculated as CBF (ml/min) = CSA (mm2) × APV (cm/s) × 0.5 × 0.6 as validated by Doucette et al. (18), where CSA is cross-sectional area (mm2). The factor of 0.5 has been empirically validated and corresponds to the correction for a parabolic velocity profile by compensating for the ratio of spectral peak velocity as measured by the Doppler system and the spatial average velocity required for the calculation of volumetric flow. The factor of 0.6 was for the unit change. Coronary resistance was derived as mean blood pressure divided by coronary blood flow.
Statistics
The continuous variables are expressed as means ± SD. Paired t-tests were used to search for possible effects of bladder distension within the groups. Unpaired t-tests were used to compare the effect of doxazosin on vascular responses between the 2 subgroups (subgroups 1A and 1B) and to compare the differences in groups of patients with or without smoking (subgroup 1A and group 2). Probability values are two-tailed, and a value of P < 0.05 is considered to be statistically significant.| |
RESULTS |
|---|
|
|
|---|
There were no baseline characteristic differences among these
three groups shown in Table 1. These groups were comparable in terms of
gender, age, lipid profile, heart rate, and blood pressure. Coronary
risk factors for coronary artery disease were evenly distributed among
the three groups. Blood pressure was significantly decreased from
113 ± 8 to 95 ± 7 mmHg after dosing doxazosin
(P < 0.001) in subgroup 1B. The reduction
of blood pressure was compatible with
1-blockade after
doxazosin administration. The baseline MLE ratios were positive and
similar in the three groups (20 ± 7% in subgroup 1A,
19 ± 8% in subgroup 1B, and 23 ± 12% in
group 2). The MLE ratio during urinary bladder distension was decreased significantly in subgroup 1A patients (3 ± 8% vs. baseline, P = 0.05) but remained unchanged in
subgroup 1B and group 2 (17 ± 12%, 10 ± 9%) compared with baseline (not significant, both). During bladder
distension, neither chest pain nor ST changes on the surface ECG
occurred. Bladder distension used in the present study
elicited fullness sensations in the suprapubic and perineal regions.
Bladder Distension and Hemodynamic Data
The intravesical pressure was similar in the three groups, namely, 21.5 ± 2.3 mmHg in subgroup 1A (range: 17-23 mmHg, filling 250-550 ml of normal saline), 20.6 ± 1.3 mmHg in subgroup 1B (range 18-23 mmHg, filling 250-550 ml of normal saline), and 21.8 ± 1.9 mmHg in group 2 (range: 17-22 mmHg, filling 225-525 ml of normal saline).An increase in intravesical pressure induced an increase in heart rate
of 11 ± 7 beats/min (range: 4-21; P = 0.05)
from baseline level of 68 ± 5 beats/min (range: 63-78) in
subgroup 1A (Table 2). Changes
in heart rate, mean blood pressure, and double product (systolic
pressure × heart rate) at rest, and during bladder distension were also comparable in the three groups.
|
Epicardial Vasomotor Response
In subgroup 1A, bladder distension significantly decreased epicardial coronary diameter by 24 ± 9% (from 1.88 ± 0.29 to 1.41 ± 0.11 mm, P = 0.0003) and decreased coronary blood flow by 29 ± 12% (from 50.5 ± 12.2 to 35.5 ± 8.9 ml/min, P = 0.003) compared with baseline values (Table 2; Fig. 1, A and C) in the stenotic vessel segments. In contrast to stenotic segments, normal vessel segments remained unchanged coronary diameters during bladder distension (Fig. 1B). In subgroup 1B, there were no significant changes in epicardial stenotic coronary diameter (Fig. 1A) and coronary blood flow (Fig. 1C) during bladder distension compared with baseline data. There were significant differences of coronary diameter (P = 0.008) and coronary blood flow (P = 0.002) between the two subgroups during bladder distension. Patients in subgroup 1A showed significant differences of coronary diameters at the stenotic segments (P < 0.0001) and coronary blood flow (P = 0.02) compared with patients in group 2 during bladder distension.
|
Resistance Vessel Response
In subgroup 1A, bladder distension significantly increased coronary resistance by 81 ± 35% (from 2.09 ± 0.89 to 3.83 ± 2.15 mmHg/min, P = 0.01), compared with baseline values (Table 2; Fig. 1D). In subgroup 1B, there were no significant changes of coronary resistance during bladder distension compared with baseline data. There were significant differences of changes of coronary resistance (P < 0.0001) between the two subgroups in response to bladder distension. Patients in subgroup 1A showed a significant difference of changes of microvascular vasomotor response to bladder distension at the stenotic segments compared with patients in group 2 (81 ± 35% vs. 24 ± 12%, P < 0.0002, Fig. 1D).| |
DISCUSSION |
|---|
|
|
|---|
The present study demonstrated that distension of the urinary
bladder decreases coronary diameter of the stenotic segments and
coronary blood flow and increases coronary resistance in the homogenous
patients with similar severities of coronary atherosclerosis. The
intravesical pressure (17-23 mmHg) and volume (225-550 ml) used in this study were within the physiological range reached during
normal filling, a physiological stimulus (22). Such
abnormal vasomotor responses during urinary bladder distension are
exaggerated in smokers. In smokers, distension of the urinary bladder
induced an exaggerated decrease in coronary blood flow despite an
increase in myocardial oxygen demand. These changes resulted in
myocardial ischemia as assessed by lactate production. Doxazosin
administration reversed the myocardial ischemia, reflecting the
mechanism of coronary vasoconstriction, and concomitant increase in
coronary vascular resistance is mediated by
1-adrenoceptors during bladder distension.
Conduit Vessel Vasoconstriction
Our results showed that vasoconstriction of conduit vessels evoked with urinary bladder distension was significantly higher in smokers. The constriction of coronary conduit vessels in response to bladder distension may be due to an exaggerated response to sympathetic activation and, in part, endothelial function. Sympathetic activation dilates normal coronary arteries but constricts atherosclerotic vessels in proportion to the severity of endothelial dysfunction (50).Two factors are related to increased sympathetic activities in this study. First, distension of urinary bladder induces catecholamine release, which evokes an increase in heart rate, blood pressure, myocardial oxygen demand, and myocardial ischemia as assessed by sinus lactate production. Distension of hollow viscera has been shown to stimulate receptors located in their walls (10, 45), which may reflexly affect coronary circulation. For instance, distension of stomach has been reported to elicit reflex increases in heart rate and blood pressure and has been related to postprandial angina (46).
Second, habitual smoking induces complex alterations in autonomic
cardiovascular control, including an increase in afferent impulses from
the distended bladder (4) and in cardiac sympathetic efferent drive (20, 33). Previous studies have
demonstrated that smoking significantly increases circulating
norepinephrine release (47). The increased norepinephrine
concentrations evoked nitric oxide release from the urinary bladder
mucosa (4). Nitric oxide released in the bladder may
modulate multiple functions by influencing the excitability of bladder
afferents (29). Node et al. (41) have
demonstrated that an
1-adrenergic antagonist attenuates
the release of nitric oxide, which decreases afferent nerve activity
and lessens adrenergic-mediated vasoconstriction. Besides, Grassi et
al. (20) have demonstrated increased coronary sinus
norepinephrine spillover in smokers, an indirect index of sympathetic
traffic to the heart. Nicotine binds to acetylcholine receptors at
autonomic ganglia, the adrenal medulla, and neuromuscular junction
(3). As a consequence of receptor stimulation, nicotine evokes the release of catecholamines and facilitates the release of
electrical stimulation-induced neurotransmitters from sympathetic nerves in cardiovascular system (3). The number of
-adrenergic receptors is increased in atherosclerotic blood vessels,
which could augment vasoconstrictor response to bladder distension
(39).
The mechanism of coronary vasoconstriction is mediated by
1-adrenoceptors. Epicardial coronary arteries are
innervated with sympathetic nerve fibers and have
1- and
2-adrenergic receptor (2). Baran et al.
(2) showed that
1-receptors are involved in
vasoconstriction of large coronary arteries during sympathetic activation, such as exercise. The increased vascular
1-
tone can explain epicardial coronary vasoconstriction during bladder distension. Furthermore,
1-adrenergic antagonist has
been shown in our study to limit coronary vasoconstriction during
bladder distension, which was consistent with the finding of Collins
and Sheridan (13) that indoramine, a selective
1-adrenergic antagonist, has been shown to limit
exercise-induced angina pectoris.
Besides, vasoconstriction of coronary arteries in response to bladder distension could also be caused by impaired endothelial function. The importance of impaired endothelial function when the sympathetic nervous system is activated has been extensively investigated. Removal of endothelium by atherosclerosis has been shown to abolish the release of nitric oxide, which may permit adrenergic agonists to activate smooth muscle to cause vasoconstriction (49). Smoking may lead to endothelial dysfunction. The effect of smoking on endothelial function of conduit vessels was examined by Celermajer et al. (9), who found an impaired brachial artery dilation in response to increased flow. Nabel et al. (38) demonstrated that sympathetic stimulation dilates normal and constricts atherosclerotic coronary arteries, which was inconsistent with our finding that vasoconstriction was noted in stenotic segments but remained unchanged in "normal reference" segments. However, a "smooth" appearance of the luminal surface on the coronary angiogram does not exclude the presence of intimal involvement with atherosclerosis. The presence of functioning endothelium in "normal reference" segments may attenuate urinary bladder distension-induced vasoconstriction.
Resistance Vessel Constriction
Distension of the urinary bladder causes greater increase of coronary vascular resistance in smokers than nonsmokers. In patients with coronary disease, coronary resistance increases during sympathetic stimulation because vasodilatory reserve has been exhausted such that
-adrenoceptor-mediated vasoconstriction is unopposed
(26). The failure of coronary blood flow to increase may
suggest either endothelial dysfunction or exaggerated sympathetic
vasoconstriction at the level of resistance, leading to uncoupling
between increased metabolic demand and coronary flow. Although
atherosclerotic lesions are confined to epicardial vessels, the
functional consequences of atherosclerosis may extend into the
microvessels. Minor et al. (35) have demonstrated
that smokers may have reduced coronary flow reserve. Heitzer et al.
(27) showed that long-term smoking is associated with
markedly reduced acetylcholine responses in forearm resistance vessels,
which further supports impaired endothelial function of resistance
vessels. Thus the failure of endothelial cells to produce or release
adequate quantities of nitric oxide occurred in resistance vessels
devoid of atheroma. Furthermore, because of a differential distribution
of
-adrenergic receptors in the canine coronary circulation, with
1-adrenoceptors mediating epicardial vasoconstriction
and
2-adrenoceptors mediating vascular resistance,
Heusch et al. (26) showed that this response of coronary
vascular resistance can be partially blocked by
1-adrenoceptor antagonists and nearly completely blocked
by
2-adrenoceptor antagonists. The finding was
consistent with our results that
1-adrenoceptor antagonist doxazosin reduced the increase in coronary resistance during
sympathetic stimulation (urinary bladder distension).
Study Limitations
This study could be criticized on the basis that heart rate was uncontrolled by cardiac pacing and double product was not held constant during the study. Although the patients were not paced during bladder distension, this decrease in mean coronary blood flow could not be explained, since an increase in heart rate is known to increase blood flow (16). Controlling double product was important because the increased double product will increase the metabolic demand, which in turn may result in vasodilatation of resistance vessels. The degrees of changes of double product among the three groups were similar. However, there was a significant increase of double product during bladder distension, which was expected to have increased coronary diameters on the basis of increased metabolic requirement. Thus the changes of double product could not be a major factor of vasoconstriction during bladder distension.Another limitation of the present study was lack of normal control for ethic reason. The need of the invasive study made it impractical to have a normal control group. Instead, each patient serves as his or her own control. Besides, there appears to be bias to the inclusion of males in this study (22 males and 2 females). Patients here were included for cardiac catheterization to rule out the possibility of coronary atherosclerosis, which is more prevalent in males than in females (31).
The third limitation was the possible change of threshold for angina depending on the intensity of afferent impulses from the distended bladder. Patients in this study experienced fullness sensation referred to perineum or suprapubic areas from the distended bladder, which was consistent with the finding of Szasz and Whyte (43), showing that pain can be elicited by distending pressures ranging from 12 to 19 mmHg. Bladder afferents in the hypogastric and pelvic nerves enter the spinal cord through the L2-L5 and S1-S4, respectively (5). These fibers are activated by noxious information from the distended bladder. Thoracic spinothalamic tract cells that receive cardiac input are strongly inhibited by afferent activity from distended urinary bladder (5). It could explain, at least in part, low incidence of chest pain (0%), although marked decreased coronary blood flow was noted during urinary bladder distension.
The fourth limitation was poor sensitivity of the surface electrocardiography to detect myocardial ischemia during bladder distension. Sutton et al. (42) reported the electrical focus caused the S-T changes to be a localized area of myocardium and therefore may not be apparent on the leads of a surface electrocardiography. Besides, the relatively short bladder distension time may not produce ischemia sufficient to develop S-T-segment changes. We did not measure intracoronary ECG and regional wall motion abnormality assessed by echocardiography, which have been proved to be more sensitive for detecting myocardial ischemia (19). Thus, although the supplied flow was less than one-half of the metabolic flow demand as indicated by the decrease of coronary flow (29%) and concomitant increase of metabolic demand (42%) compared with predistension values, none of the patients in subgroup 1A demonstrated S-T changes on surface electrocardiograms.
The fifth limitation refers to the possibility that the
-adrenergic
antagonist used in this study provided an insufficient dose. However,
this is unlikely, because the mean blood pressure reduction after
complete blockade of the
-adrenergic pressor effects was 13 mmHg
reported by Guth et al. (21), which is similar to our
result of 18 mmHg.
Finally, although previous studies have used
2-adrenergic blockers to demonstrate the role of
adrenergic receptors in mediating coronary vasoconstriction effects, we
did not use these, which will increase circulating norepinephrine and
myocardial oxygen consumption (30). Such adverse
myocardial effects will increase the complexity of effects of
2-adrenergic blockers on coronary vasomotor function.
Clinical Implication
Urinary bladder distension performed in this study constitutes a physiological form of stress and therefore may have relevance to the clinical setting. Coronary artery vasomotor may have a significant role in the pathogenesis of ischemic myocardial disease. During bladder distension the reflex coronary vasoconstriction would limit the expected coronary vasodilatation, which is secondary to the concomitant reflex increases in heart rate and arterial blood pressure. Traditionally, relation of bladder distension to myocardial ischemia has been related to increased systolic pressure × heart rate (double product), an index of myocardial oxygen requirement. From this study another potentially important contributing mechanism is the reflex coronary vasoconstriction. Such vasoconstriction response of resistance vessels distal to the stenosis could further limit the blood supply to the myocardium and contribute to myocardial ischemia during bladder distension.Smoking can lower the angina threshold and increase the frequency of
ischemic events by coronary vasoconstriction in the settings of high
circulating catecholamine such as urinary bladder distension. Besides,
focal constriction of epicardial vessels in patients with early
atherosclerosis could lead to coronary spasm and further vascular
endothelial damage and predispose to plaque rupture. The study
suggested that the
1-adrenoceptor blockade is unique among drugs for obstructive coronary artery disease in having a
beneficial effect on coronary blood flow in smokers.
Conclusions
The present study showed that urinary bladder distension reflexly caused an abnormal vasomotor response of epicardial vasoconstriction and a concomitant increased coronary resistance even in patients with early coronary atherosclerosis. The abnormal vasomotor responses during urinary bladder distension are exaggerated in smokers. The response involved efferent and/or afferent sympathetic mechanisms related to
1-adrenoceptors. Pretreated administration of doxazosin had reversed the decreased coronary blood flow during bladder distension toward baseline.
| |
ACKNOWLEDGEMENTS |
|---|
We thank our colleagues in the catheterization laboratory for technical assistance.
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: T.-M. Lee, Dept. of Internal Medicine, Cardiology Section, National Taiwan Univ. Hospital, 7 Chung-Shan S. Rd., Taipei, Taiwan 600 (E-mail: tmlee{at}ha.mc.ntu.edu.tw).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 1 February 2000; accepted in final form 18 July 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Antony, I,
Aptecar E,
Lerebours G,
and
Nitenberg A.
Coronary artery constriction caused by cold pressor test in human hypertension.
Hypertension
24:
212-219,
1994
2.
Baran, KW,
Robert JB,
Dai X,
and
Schwartz JS.
Effects of
-adrenergic blockade with prazosin on large coronary diameter during exercise.
Circulation
85:
1139-1145,
1992
3.
Benowitz, NL.
Pharmacologic aspects of cigarette smoking and nicotine addiction.
N Engl J Med
319:
1318-1330,
1988[ISI][Medline].
4.
Birder, LA,
Apodaca G,
de Groat WC,
and
Kanai AJ.
Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder.
Am J Physiol Renal Physiol
275:
F226-F229,
1998
5.
Brennau, TJ,
Oh UT,
Hobbs SF,
Garrison DW,
and
Foreman RD.
Urinary bladder and hindlimb afferent input inhibits activity of primate T2-T5 spinothalamic tract neurons.
J Neurophysiol
61:
573-588,
1989
6.
Brown, BG,
Lee AB,
Bolson EL,
and
Dodge HT.
Reflex constriction of significant coronary stenosis as a mechanism contributing to ischemic left ventricular dysfunction during isometric exercise.
Circulation
70:
18-24,
1984
7.
Camici, PG,
Marraaccini P,
Gistri R,
Salvadori PA,
Sorace O,
and
L'Abbate A.
Adrenergically mediated coronary vasoconstriction in patients with syndrome X.
Cardiovasc Drugs Ther
8:
221-226,
1994[ISI][Medline].
8.
Cass, AS,
Ward BD,
and
Markland C.
Comparison of slow and rapid fill cystometry using liquid and air.
J Urol
104:
104-108,
1970[ISI][Medline].
9.
Celermajer, DS,
Sorensen KE,
Georgakopoulos D,
Bull C,
Thomas O,
Robinson J,
and
Deanfield JE.
Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.
Circulation
88:
2149-2155,
1993
10.
Cervero, F.
Sensory innervation of the viscera: peripheral basis of visceral pain.
Physiol Rev
74:
95-138,
1994
11.
Cevese, A,
Drinkhill MJ,
Mary DASG,
Patel P,
Schena F,
and
Vacca G.
The effect of distension of the urinary bladder on coronary blood flow in anaesthetized dogs.
Exp Physiol
76:
409-421,
1991[Abstract].
12.
Chilian, WM.
Functional distribution of
1- and
2-adrenergic receptors in the coronary microcirculation.
Circulation
84:
2108-2122,
1991
13.
Collins, P,
and
Sheridan D.
Improvement in angina pectoris with alpha adrenoceptor blockade.
Br Heart J
53:
488-492,
1985
14.
Denny-Brown, D,
and
Robertson EG.
On the physiology of micturition.
Brain
56:
149-190,
1933.
15.
De Simone, G,
Devereux RB,
Daniels SR,
Koren MJ,
Meyer RA,
and
Laragh JH.
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk.
J Am Coll Cardiol
25:
1056-1062,
1995[Abstract].
16.
Di Lavore, P,
Gattullo D,
Guiot C,
Losano G,
Mary DASG,
Vacca G,
and
Vono P.
Effect of tachycardia and vasoconstriction of left circumflex artery on coronary flow and pressure in anaesthetized dogs.
J Physiol (Lond)
406:
469-481,
1988
17.
Dixon, JS,
and
Gilpin CJ.
Presumptive sensory axons of the human urinary bladder: a fine structural study.
J Anat
151:
199-207,
1987[ISI][Medline].
18.
Doucette, JW,
Corl PD,
Payne HM,
Flynn AE,
Goto M,
Nassi M,
and
Segal J.
Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity.
Circulation
85:
1899-1911,
1992
19.
Eltchaninoff, H,
Cribier A,
Tron C,
Derumeaux G,
Koning R,
Hecketsweiller B,
and
Letac B.
Adaptation to myocardial ischemia during coronary angioplasty demonstrated by clinical, electrocardiographic, echocardiographic, and metabolic parameters.
Am Heart J
133:
490-496,
1997[ISI][Medline].
20.
Grassi, G,
Seravalle G,
Calhoun DA,
Bolla GB,
Giannattasio C,
Marabini M,
Del Bo A,
and
Mancia G.
Mechanisms responsible for sympathetic activation by cigarette smoking in humans.
Circulation
90:
248-253,
1994
21.
Guth, BD,
Thaulow E,
Heusch G,
Seitelberger R,
and
Ross J, Jr.
Myocardial effects of selective
-adrenoceptor blockade during exercise in dogs.
Circ Res
66:
1703-1712,
1990
22.
Habler, HJ,
Janig W,
and
Kolzenburg M.
Myelinated primary afferents of the sacral spinal cord responding to slow filling and distension of the cat urinary bladder.
J Physiol (Lond)
463:
449-460,
1993
23.
Heusch, G.
-adrenergic mechanisms in myocardial ischemia.
Circulation
81:
1-13,
1990
24.
Heusch, G,
Baumgart D, P,
Camici Chilian W,
Gregorini L,
Hess O,
Indolfi C,
and
Rimoldi O.
-adrenergic coronary vasoconstriction and myocardial ischemia in humans.
Circulation
101:
689-694,
2000
25.
Heusch, G,
and
Deussen A.
The effects of cardiac sympathetic nerve stimulation on the perfusion of stenotic coronary arteries in the dog.
Circ Res
53:
8-15,
1983
26.
Heusch, G,
Deussen A,
Schipke J,
and
Thamer V.
1- and
2-adrenoceptor-mediated vasoconstriction of large and small canine coronary arteries in vivo.
J Cardiovasc Pharmacol
6:
961-968,
1984[ISI][Medline].
27.
Heitzer, T,
Yla-Herttuala S,
Luoma J,
Kurz S,
Munzel T,
Just H,
Olschewski M,
and
Drexler H.
Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL.
Circulation
93:
1346-1353,
1996
28.
Julius, BK,
Vassalli G,
Mandinov L,
and
Hess OM.
Alpha-adrenoceptor blockade prevents exercise-induced vasoconstriction of stenotic coronary arteries.
J Am Coll Cardiol
33:
1499-1505,
1999
29.
Kakizaki, H,
and
de Groat WC.
Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation.
J Urol
155:
355-360,
1996[ISI][Medline].
30.
Langer, SZ.
Presynaptic regulation of the release of catecholamines.
Pharmacol Rev
32:
337-362,
1981[Abstract].
31.
Lauer, MS,
Pashkow FJ,
Snader CE,
Harvey SA,
Thomas JD,
and
Marwick TH.
Gender and referral for coronary angiography after treadmill thallium testing.
Am J Cardiol
78:
278-283,
1996[ISI][Medline].
32.
Lee, TM,
Chu CC,
Hsu YM,
Chen MF,
Liau CS,
and
Lee YT.
Exaggerated acute luminal loss a few minutes after percutaneous transluminal coronary angioplasty in patients with recent myocardial infarction compared with stable angina: an intracoronary ultrasound study.
Cathet Cardiovasc Diagn
41:
32-39,
1997[ISI][Medline].
33.
Lucini, D,
Bertocchi F,
Malliani A,
and
Pagani M.
A controlled study of the autonomic changes produced by habitual cigarette smoking in healthy subjects.
Cardiovasc Res
31:
633-639,
1996[ISI][Medline].
34.
Mary, DASG
The urinary bladder and cardiovascular reflexes.
Int J Cardiol
23:
11-17,
1989[ISI][Medline].
35.
Minor, RL,
Oskarsson H,
Rossen JD,
and
Winniford MD.
Is coronary flow reserve reduced in chronic cigarette smokers?
Circulation
86, Suppl I:
I117,
1992.
36.
Mudge, GH,
Grossman W,
Mills RM,
Lesch M,
and
Braunwald E.
Reflex increase in coronary vascular resistance in patients with ischemic heart disease.
N Engl J Med
295:
1333-1337,
1976[Abstract].
37.
Multiple Risk Factor Intervention Trial Research Group.
Multiple Risk Factor Intervention Trial Risk factor changes and mortality results.
JAMA
248:
1465-1477,
1982[Abstract].
38.
Nabel, EG,
Ganz P,
Gordon JB,
Alexander RW,
and
Selwyn AP.
Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test.
Circulation
77:
43-52,
1988
39.
Nanda, V,
and
Henry PD.
Increased serotonergic and alpha-adrenergic receptors in aortas from rabbits fed a high cholesterol diet (Abstract).
Clin Res
30:
209,
1982.
40.
Niedermaier, ON,
Smith ML,
Beightol LA,
Zukowska-Grojec Z,
Goldstein DS,
and
Eckberg DL.
Influence of cigarette smoking on human autonomic function.
Circulation
88:
562-571,
1993
41.
Node, K,
Kitakaze M,
Kosaka H,
Komamura K,
Minamino T,
Tada M,
Inoue M,
Hori M,
and
Kamada T.
Role of
1-adrenoceptor activity in the release of nitric oxide during ischemia of the canine heart.
Biochem Biophys Res Commun
212:
1133-1138,
1995[ISI][Medline].
42.
Sutton, PMI,
Taggart P,
Lab M,
Runnalls ME,
O'Brien W,
and
Treasure T.
Alternans of epicardial repolarization as a localized phenomenon in man.
Eur Heart J
12:
70-78,
1991
43.
Szasz, JJG,
and
Whyte AM.
Effects of distension of the bladder and contraction of sphincters on blood pressure.
Br Med J
2:
208-210,
1967.
44.
Tadaoka, S,
Kagiyama M,
Hiramatsu O,
Ogasawara Y,
Tsujioka K,
Wada Y,
Sawayama T,
and
Kajiya F.
Accuracy of 20-Mhz Doppler catheter coronary artery velometry for measurement of coronary blood flow velocity.
Cathet Cardiovasc Diagn
19:
205-213,
1990[ISI][Medline].
45.
Vacca, G,
Battaglia A,
Grossini E,
Mary DASG,
and
Molinari C.
Reflex coronary vasoconstriction caused by gallbladder distension in anesthetized pigs.
Circulation
94:
2201-2209,
1996
46.
Vacca, G,
and
Vono P.
The primary reflex effects of distension of the stomach on heart rate, arterial pressure and left ventricular contractility in the anaesthetized pig.
Pflügers Arch
425:
248-255,
1993[ISI][Medline].
47.
Winniford, MD,
Wheelan KR,
Kremers MS,
Ugolini V,
van der Berg E, Jr,
Niggemann EH,
Jansen DE,
and
Hillis LD.
Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease: evidence for adrenergically mediated alterations in coronary artery tone.
Circulation
73:
662-667,
1986
48.
Yeung, AC,
Vekshtein VI,
Krantz DS,
Vita JA,
Ryan TJ, Jr,
Ganz P,
and
Selwyn AP.
The effect of atherosclerosis on the vasomotor response of coronary arteries to metal stress.
N Engl J Med
325:
1551-1556,
1991[Abstract].
49.
Yokoyama, M,
Akita H,
Mizutani T,
Fukazaki H,
and
Watanabe Y.
Hyperreactivity of coronary arterial smooth muscles in response to ergonovine from rabbits with hereditary hyperlipidemia.
Circ Res
53:
63-71,
1983
50.
Zeiher, AM,
Drealer H,
Wollschlager H,
and
Just H.
Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis.
Circulation
83:
391-401,
1991
This article has been cited by other articles:
![]() |
H.-J. Yu, B.-R. Lin, H.-S. Lee, C.-T. Shun, C.-C. Yang, T.-Y. Lai, C.-T. Chien, and S.-M. Hsu Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat liver Am J Physiol Renal Physiol, May 1, 2005; 288(5): F1005 - F1014. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |